UFP Technologies (UFPT) Piper Sandler 37th Annual Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Piper Sandler 37th Annual Healthcare Conference summary
3 Dec, 2025Company overview and capabilities
Specializes in single-use and single-patient Medtech devices, with $600M revenue and 5,000 associates in 21 factories across five countries.
Combines design engineering, materials expertise, and precision manufacturing to support product development and protection.
Maintains strong vendor partnerships, often securing exclusive or semi-exclusive access to critical materials.
Engages in rapid prototyping, custom equipment creation, and in-house tooling for quick design iterations.
Quality systems are co-developed with customers, with many products 100% tested for patient safety.
Business model and customer relationships
Operates a virtuous cycle where each project enhances expertise and deepens customer relationships.
Focuses on long-term manufacturing contracts, with examples in robotic surgery, infection prevention, and patient safety.
Forward integration and acquisitions expand capabilities and value to customers.
Sole-source provider for several successful programs, leveraging redundant manufacturing facilities.
Sub-markets like robotic surgery and patient services are experiencing double-digit growth.
Growth strategy and acquisitions
Pursues a two-prong growth strategy: internal growth by focusing on the most profitable business segments and strategic acquisitions to add value.
Acquisitions are guided by a technology roadmap developed with customer input, targeting new geographies and capabilities.
Recent acquisitions have shifted revenue mix to $550M Medtech out of $600M total, tripling revenue in four years.
Expanded global footprint with facilities in the U.S., Ireland, Mexico, Dominican Republic, and Costa Rica.
Customer-funded development screens for serious partners and funds engineering resources.
Latest events from UFP Technologies
- Exclusive materials, strategic acquisitions, and strong contracts fuel high-margin growth.UFPT
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - MedTech-focused manufacturer targets 12–18% revenue growth and 17–20% margins via innovation and acquisitions.UFPT
Investor presentation3 Mar 2026 - 2025 sales up 19.5% to $602.8M, with record net income and strong medical market growth.UFPT
Q4 202525 Feb 2026 - Exclusive materials, strategic acquisitions, and medtech focus drive robust growth and margins.UFPT
15th Annual Midwest IDEAS Investor Conference23 Jan 2026 - Executing on acquisitions and expanding in med tech, with strong customer partnerships and margin gains.UFPT
CJS Securities Annual New Ideas For the New Year Conference 202410 Jan 2026 - Annual meeting to vote on directors, executive pay, auditor, and governance practices.UFPT
Proxy Filing2 Dec 2025 - Record Q1 sales up 41% to $148.1M, led by medical growth and strategic expansion.UFPT
Q1 202524 Nov 2025 - Strong growth in medical device outsourcing, driven by innovation, acquisitions, and client focus.UFPT
16th Annual Midwest Ideas Conference23 Nov 2025 - Q2 sales up 37% to $151.2M, MedTech up 46%, with margin rebound expected in Q4.UFPT
Q2 202523 Nov 2025